Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and …
DMG Halpin, GJ Criner, A Papi, D Singh… - American journal of …, 2021 - atsjournals.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised
many questions about the management of patients with chronic obstructive pulmonary …
many questions about the management of patients with chronic obstructive pulmonary …
Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis
E Karakike, EJ Giamarellos-Bourboulis… - Critical care …, 2021 - journals.lww.com
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …
respiratory tract infection, which can induce respiratory failure and multiple organ …
An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline
Background: This document updates previously published Clinical Practice Guidelines for
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …
Asthma in adult patients with COVID-19. Prevalence and risk of severe disease
Rationale: Health outcomes of people with coronavirus disease (COVID-19) range from no
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …
[HTML][HTML] Clinical predictive models for COVID-19: systematic study
Background COVID-19 is a rapidly emerging respiratory disease caused by SARS-CoV-2.
Due to the rapid human-to-human transmission of SARS-CoV-2, many health care systems …
Due to the rapid human-to-human transmission of SARS-CoV-2, many health care systems …
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis
Background There are concerns that the use of non-steroidal anti-inflammatory drugs
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …
[HTML][HTML] The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2
SS Foo, MC Cambou, T Mok, VM Fajardo, KL Jung… - Cell Reports …, 2021 - cell.com
While pregnancy increases the risk for severe COVID-19, the clinical and immunological
implications of COVID-19 on maternal-fetal health remain unknown. Here, we present the …
implications of COVID-19 on maternal-fetal health remain unknown. Here, we present the …
Mesenchymal stem cell-derived extracellular vesicles carrying miRNA as a potential multi target therapy to COVID-19: an in silico analysis
IC Schultz, APS Bertoni, MR Wink - Stem Cell Reviews and Reports, 2021 - Springer
In the end of 2019 COVID-19 emerged as a new threat worldwide and this disease present
impaired immune system, exacerbated production of inflammatory cytokines, and …
impaired immune system, exacerbated production of inflammatory cytokines, and …
Trends in ICU mortality from coronavirus disease 2019: a tale of three surges
SC Auld, KRV Harrington, MW Adelman… - Critical care …, 2022 - journals.lww.com
OBJECTIVES: To determine the association between time period of hospitalization and
hospital mortality among critically ill adults with coronavirus disease 2019. DESIGN …
hospital mortality among critically ill adults with coronavirus disease 2019. DESIGN …
Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa
W Jassat, C Mudara, L Ozougwu, S Tempia… - MedRxiv, 2021 - medrxiv.org
ABSTRACT Introduction South Africa experienced its first wave of COVID-19 peaking in mid-
July 2020 and a larger second wave peaking in January 2021, in which the SARS-CoV-2 …
July 2020 and a larger second wave peaking in January 2021, in which the SARS-CoV-2 …